Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma

Oral Oncology

Volumn 36, Issue 1, 2000, Pages 95-99

  Chen, Q ^a   Samaranayake, L P ^a   Zhou, H ^a   Xiao, L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Homozygous deletion; Oral; PTEN; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DNA SEQUENCE; FEMALE; GENE DELETION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUPPRESSOR GENE; TUMOR CELL LINE;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0033991192     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00068-8     Document Type: Article

References (27)

1. Parkin D.M., Pisani P., Ferlay J Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer. 54:1993;594-606.
2. Chen Q., Pen W., Fu J.L., Li B.Q. Suppression of human oral squamous cell line growth in vitro by wild type p53 gene. National Journal of Medicine in China. 76:1996;876-877.
3. Chen Q., Luo G., Li B., Samaranayake L.P. Expression of p16 and cdk4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. Journal of Oral Pathology and Medicine. 28:1999;158-164.
4. Schneeberger C., Eder S., Swoboda H., Ullrich R., Zeillinger R. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas. Oral Oncology. 34:1998;257-260.
5. Li J., Yen C., Liaw D.et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
6. Steck P.A., Pershouse M.A., Jasser S.A.et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics. 15:1997;356-362.
7. Risinger J.I., Hayes S.K., Berchuck A, Barrett J.C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Research. 57:1997;4736-4738.
8. Tashiro H., Blazes M.S., Wu R.et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. 57:1997;3935-3940.
9. Teng D.H., Rong H., Lin H.et al. MMAC1/PTEN mutaions in primary tumor specimens and tumor cell lines. Cancer Research. 57:1997;5221-5225.
10. Cairns P., Okami K., Halachimi S.et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Research. 57:1997;4997-5000.
11. Guldberg P., Straten P.T., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutaion is a frequent event in malignant melanoma. Cancer Research. 57:1997;3660-3663.
12. Liu W., James C.D., Fredrick L., Jenkins R.B. PTEN/MMAC1 mutaions and EGFR amplification in glioblastomas. Cancer Research. 57:1997;5254-5257.
13. Pennisi E. New tumor suppressor found - twice. Science. 275:1997;1876-1878.
14. Maxwell G.L., Risinger J.I., Tong B.et al. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers. Gynecologic Oncology. 70:1998;13-16.
15. Dong J.T., Sipe T.W., Hyytinen E.R.et al. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate. Oncogene. 17:1998;1979-1982.
16. Shao X., Tandon R., Samara G.et al. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma. International Journal of Cancer. 77:1998;684-688.
17. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin/NewYork: Springer, 1997. p. 11-13.
18. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning, a laboratory manual. 2nd ed. 1989;Cold Harbor Laboratory Press, Cold spring, New York.
19. Wang S.I., Puc J., Li J.et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Research. 57:1997;4183-4186.
20. Liaw D., March D.J., Li J.et al. Germline mutaions of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics. 16:1997;64-67.
21. Zhang S.Y., Klein-Szanto A.J.P., Sauter E.R.et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Research. 54:1994;5050-5053.
22. Bostrom J., Cobbers J.M.J.L., Wolter M.et al. Mutations of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q1. Cancer Research. 58:1998;29-33.
23. Connor M., Ferguson-Smith M. Essential medical genetics. 5th ed. 1997;Blackwell Science, Oxford, UK.
24. Wang S.I., Parsons R., Ittmann M. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clinical Cancer Research. 4:1998;811-815.
25. Yokomizo A., Tindall D.J., Hartmann L., Jenkins R.B., Smith D.I., Liu W. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer. International Journal of Oncology. 13:1998;101-105.
26. Cairns P., Evron E., Okami K.et al. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene. 16:1998;3215-3218.
27. Watanabe K., Peraud A., Gratas C., Wakai S., Kleihues P., Ohgaki H. P53 and PTEN mutations in gemistocytic astrocytomas. Acta Neuropathology. 95:1998;559-564.